You are here

Article info

Article menu
Basic tumor immunology
Original research
ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers

Authors

  • Zheng-Zheng Yu Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaResearch Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaNational Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Yun-Ya Liu Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaNational Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Wei Zhu Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Ding Xiao Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Wei Huang Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Shan-Shan Lu Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Hong Yi Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Ting Zeng Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Xue-Ping Feng Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Li Yuan Department of Nuclear Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Jie-Ya Qiu Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Di Wu Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Qi Wen Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Jian-Hua Zhou Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Wei Zhuang Department of Thoracic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Zhi-Qiang Xiao Department of Pathology, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaResearch Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaThe Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital of Central South University, Changsha, Hunan, ChinaNational Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles

Citation

Yu Z, Liu Y, Zhu W, et al
ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
Journal for ImmunoTherapy of Cancer 2023;11:e006345. doi: 10.1136/jitc-2022-006345
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.